Medartis Holding AG (SWX:MED)
Switzerland · Delayed Price · Currency is CHF 79.60
-0.80 (-1.00%)
Apr 2, 2026, 10:36 AM CET
Medartis Holding AG Market Cap
Medartis Holding AG has a market cap or net worth of 999.58 million as of April 2, 2026. Its market cap has increased by 5.03% in one year.
Market Cap
999.58M
Enterprise Value
1.12B
Revenue
269.26M
Ranking
n/a
PE Ratio
120.00
Stock Price
79.60
Market Cap Chart
Since March 23, 2018, Medartis Holding AG's market cap has increased from 726.81M to 999.58M, an increase of 37.53%. That is a compound annual growth rate of 4.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 999.58M | -8.82% |
| Dec 30, 2025 | 1.10B | 42.46% |
| Dec 30, 2024 | 769.51M | -25.88% |
| Dec 29, 2023 | 1.04B | 6.78% |
| Dec 30, 2022 | 972.24M | -36.80% |
| Dec 30, 2021 | 1.54B | 180.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 249.75B |
| Novartis AG | 227.34B |
| Galderma Group AG | 35.09B |
| Lonza Group AG | 34.54B |
| Cosmo Pharmaceuticals | 1.30B |
| Aevis Victoria | 1.14B |
| SKAN Group AG | 957.80M |
| PolyPeptide Group AG | 871.37M |